Reaching People, Changing Lives

At Aurinia Pharmaceuticals, we’re developing and delivering innovative products to patients suffering from debilitating diseases such as lupus nephritis (LN).

How We’re Helping Patients

Latest News

February 14, 2017 • 12:00am EST

Aurinia Announces Results from Japanese Phase I Ethnic Bridging Study for Voclosporin

Read Press Release View All News

February 10, 2017 • 12:00am EST

Aurinia’s New CEO, Richard Glickman, to Present at Leerink Partners 6th Annual Global Healthcare Conference

Read Press Release View All News

February 6, 2017 • 12:00am EST

Aurinia Announces Appointment of Company Founder, Dr. Richard M. Glickman, as its New Chief Executive Officer

Read Press Release View All News

Email Alerts

Stay informed and receive company updates straight to your inbox

Sign Up Today